Northcoast Research Analysts Cut Earnings Estimates for Integer Holdings Co. (ITGR)

Integer Holdings Co. (NYSE:ITGR) – Research analysts at Northcoast Research reduced their FY2017 earnings estimates for Integer in a research note issued to investors on Wednesday. Northcoast Research analyst D. Keiser now forecasts that the medical equipment provider will earn $2.63 per share for the year, down from their previous forecast of $2.65. Northcoast Research currently has a “Neutral” rating on the stock. Northcoast Research also issued estimates for Integer’s Q1 2019 earnings at $0.78 EPS, Q2 2019 earnings at $0.94 EPS, Q3 2019 earnings at $0.91 EPS and Q4 2019 earnings at $0.88 EPS.

Several other brokerages have also recently issued reports on ITGR. TheStreet upgraded Integer from a “c+” rating to a “b-” rating in a research report on Wednesday, October 18th. ValuEngine raised Integer from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research lowered Integer from a “buy” rating to a “hold” rating in a report on Tuesday, January 23rd. BidaskClub lowered Integer from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 28th. Finally, Royal Bank of Canada reaffirmed a “neutral” rating on shares of Integer in a report on Friday, October 27th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Integer presently has a consensus rating of “Hold” and a consensus price target of $51.00.

Integer (ITGR) opened at $43.75 on Thursday. The stock has a market capitalization of $1,402.97, a PE ratio of 16.29, a P/E/G ratio of 0.93 and a beta of 1.05. Integer has a 52-week low of $33.90 and a 52-week high of $55.20. The company has a debt-to-equity ratio of 1.95, a current ratio of 2.58 and a quick ratio of 1.37.

Large investors have recently made changes to their positions in the company. Meeder Asset Management Inc. boosted its stake in shares of Integer by 411.1% during the 3rd quarter. Meeder Asset Management Inc. now owns 2,034 shares of the medical equipment provider’s stock worth $104,000 after acquiring an additional 1,636 shares in the last quarter. Zions Bancorporation purchased a new stake in shares of Integer during the 3rd quarter worth approximately $174,000. Amalgamated Bank purchased a new stake in shares of Integer during the 3rd quarter worth approximately $212,000. Advisor Group Inc. boosted its stake in shares of Integer by 340.0% during the 4th quarter. Advisor Group Inc. now owns 4,154 shares of the medical equipment provider’s stock worth $188,000 after acquiring an additional 3,210 shares in the last quarter. Finally, Bessemer Group Inc. purchased a new stake in shares of Integer during the 3rd quarter worth approximately $220,000. 95.57% of the stock is currently owned by institutional investors and hedge funds.

In other news, VP Timothy G. Mcevoy sold 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $49.35, for a total transaction of $172,725.00. Following the sale, the vice president now owns 32,401 shares of the company’s stock, valued at approximately $1,598,989.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Gary J. Haire sold 731 shares of the business’s stock in a transaction that occurred on Wednesday, January 3rd. The stock was sold at an average price of $44.89, for a total value of $32,814.59. Following the sale, the chief financial officer now directly owns 1,911 shares in the company, valued at approximately $85,784.79. The disclosure for this sale can be found here. Insiders sold a total of 69,876 shares of company stock worth $3,259,136 in the last ninety days. 4.80% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This article was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.americanbankingnews.com/2018/02/15/northcoast-research-analysts-cut-earnings-estimates-for-integer-holdings-co-itgr.html.

Integer Company Profile

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply